All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @alyssamax7 on TikTok · 36s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @alyssamax7's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00The day, the music died
  2. 0:07And they were singing
  3. 0:09Pine, pine, pine
  4. 0:14Drove my Chevy to the levee
  5. 0:17But the levee was dry
  6. 0:20And then good old boys were drinking whiskey
  7. 0:24And I sang in this will be the day that I died
  8. 0:29This will be the day that I died

@alyssamax7's Wegovy claims need a closer look

Alyssa Max

TikTok creator

110.3K viewsWatch on TikTok

Quick answer

The video contains no clinical content despite being tagged with GLP-1 and Wegovy-related hashtags. The audio is song lyrics from Don McLean's American Pie, with no reference to semaglutide, tirzepatide, weight loss mechanisms, or any health topic. No clinical claims require evaluation, though the hashtag context warrants platform-level flagging for misleading categorization.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @alyssamax7's Wegovy claims need a closer look, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@alyssamax7's Wegovy claims need a closer look" from Alyssa Max. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video contains no clinical content despite being tagged with GLP-1 and Wegovy-related hashtags.

The reason this review is not generic is the source wording and the canonical claim label "glp1 wegovy glp1 weightloss fyp." In this clip, the useful excerpt is: "The day, the music died And they were singing Pine, pine, pine Drove my Chevy to the levee But the levee was dry And then good old boys were drinking whiskey And I sang in this will be the day that I died This will be the day that I died" That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The hashtags and do not reflect the video content and appear to be used for algorithmic reach rather than informational accuracy.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video contains no clinical content despite being tagged with GLP-1 and Wegovy-related hashtags.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video contains no clinical content despite being tagged with GLP-1 and Wegovy-related hashtags. The audio is song lyrics from Don McLean's American Pie, with no reference to semaglutide, tirzepatide, weight loss mechanisms, or any health topic. No clinical claims require evaluation, though the hashtag context warrants platform-level flagging for misleading categorization.
  • This video contains no GLP-1 health claims. The entire audio is song lyrics from Don McLean's 1971 song American Pie.
  • The hashtags #wegovy and #glp1 do not reflect the video content and appear to be used for algorithmic reach rather than informational accuracy.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • This video contains no GLP-1 health claims. The entire audio is song lyrics from Don McLean's 1971 song American Pie.
  • The hashtags #wegovy and #glp1 do not reflect the video content and appear to be used for algorithmic reach rather than informational accuracy.
  • Semaglutide 2.4 mg (Wegovy) produced 14.9% mean weight loss over 68 weeks in the STEP 1 trial (Wilding et al., 2021, NEJM), the foundational evidence for its approval.
  • Tirzepatide 15 mg (Zepbound) produced up to 20.9% mean weight loss in SURMOUNT-1 (Jastreboff et al., 2022, NEJM), making it among the most effective approved weight loss medications.
  • Compounded semaglutide and tirzepatide are not equivalent to brand-name Wegovy or Zepbound. The FDA has not approved compounded versions and has flagged safety concerns.
  • GLP-1 receptor agonists are not cures for obesity or type 2 diabetes. Weight loss outcomes depend on continued use, and weight regain after discontinuation is well-documented.
  • Any dosing or treatment decisions for GLP-1 medications should come from a licensed clinician, not social media content tagged with trending health hashtags.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @alyssamax7 actually say?

Nothing about GLP-1 medications. At all. The entire transcript is a loose, partially misremembered rendition of Don McLean's "American Pie" from 1971. Lines like "drove my Chevy to the levee but the levee was dry" and "this will be the day that I died" are song lyrics, not health claims. There is no medical content here to fact-check in the traditional sense.

The video was tagged with #wegovy, #glp1, and #weightloss, which is how it ended up in a health content review queue. But the gap between those hashtags and the actual audio content is total. Either the creator posted the wrong audio, used trending health hashtags to chase the algorithm, or this was some kind of creative bit that did not land with any discernible context. Whatever the reason, the content and the tags have nothing to do with each other.

Does the science back this up?

There is no claim to evaluate against the science. The video contains zero assertions about semaglutide, tirzepatide, weight loss mechanisms, GLP-1 receptor agonists, dosing, side effects, or any related topic. Applying clinical literature here would be absurd.

That said, since the hashtags pulled this into a GLP-1 review, it is worth noting what the actual evidence base looks like for the drugs being referenced in the tags. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed semaglutide 2.4 mg weekly produced mean body weight reduction of 14.9% over 68 weeks in adults without diabetes. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide at 15 mg produced up to 20.9% mean weight reduction. These are real, peer-reviewed findings. They are just completely irrelevant to a video about a 1971 folk rock song.

What did they get wrong (or right)?

The creator got the lyrics slightly wrong, which is not a health claim but is worth noting for accuracy's sake. The actual lyric is "the day the music died," not "the day, the music died." More notably, "this will be the day that I died" is a misquote of "this'll be the day that I die." These are minor errors in a song context, but pattern-of-accuracy matters in any content review.

On health claims: there are none to grade. Right or wrong does not apply. What is worth flagging is the hashtag strategy. Tagging unrelated content with #wegovy and #glp1 to capture search traffic is a form of platform manipulation that muddies health information ecosystems. When people search GLP-1 content looking for legitimate information about medication side effects, dosing timelines, or clinical outcomes, they do not benefit from finding American Pie karaoke. This is not a medical harm, but it is a content quality problem.

What should you actually know?

If you landed on this video expecting information about Wegovy or GLP-1 medications, you were misled by the tags, not the creator's words. Here is what actually matters if you are researching these drugs.

  • Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
  • These are not interchangeable with compounded versions. Compounded semaglutide and tirzepatide are not FDA-approved and have different purity, potency, and formulation standards.
  • Common side effects include nausea, vomiting, diarrhea, and constipation, particularly during dose escalation. Wilding et al. (2021, NEJM) reported 74.2% of semaglutide patients experienced GI adverse events.
  • No GLP-1 receptor agonist has been approved as a cure for any disease. Weight reduction and glycemic improvement are clinical outcomes, not cures.
  • A telehealth provider or endocrinologist is the appropriate source for dosing decisions, not TikTok content, regardless of the hashtags attached to it.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Alyssa Max · TikTok creator

110.3K views on this video

#wegovy #glp1 #weightloss #fyp

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about this video contains no glp-1 health claims. the entire audio?

This video contains no GLP-1 health claims. The entire audio is song lyrics from Don McLean's 1971 song American Pie.

What does the video say about the hashtags #wegovy?

The hashtags #wegovy and #glp1 do not reflect the video content and appear to be used for algorithmic reach rather than informational accuracy.

What does the video say about semaglutide 2.4 mg (wegovy) produced 14.9% mean weight loss over?

Semaglutide 2.4 mg (Wegovy) produced 14.9% mean weight loss over 68 weeks in the STEP 1 trial (Wilding et al., 2021, NEJM), the foundational evidence for its approval.

What does the video say about tirzepatide 15 mg (zepbound) produced up to 20.9% mean weight?

Tirzepatide 15 mg (Zepbound) produced up to 20.9% mean weight loss in SURMOUNT-1 (Jastreboff et al., 2022, NEJM), making it among the most effective approved weight loss medications.

What does the video say about compounded semaglutide?

Compounded semaglutide and tirzepatide are not equivalent to brand-name Wegovy or Zepbound. The FDA has not approved compounded versions and has flagged safety concerns.

What does the video say about glp-1 receptor agonists?

GLP-1 receptor agonists are not cures for obesity or type 2 diabetes. Weight loss outcomes depend on continued use, and weight regain after discontinuation is well-documented.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Alyssa Max, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.